Matches in Nanopublications for { ?s ?p "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1276366.RAR9Vy5L9Y9eEvMFDDuHFHt4NweIyFHAiQYml_9lST8qw130_assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276366.RAR9Vy5L9Y9eEvMFDDuHFHt4NweIyFHAiQYml_9lST8qw130_provenance.
- NP1276362.RAjl08tYrG5REPVzEyWcqpo9vdWIgq6BxT9F9BqJ5DD40130_assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276362.RAjl08tYrG5REPVzEyWcqpo9vdWIgq6BxT9F9BqJ5DD40130_provenance.
- NP1276365.RAg2dltZvb6UtYXiyF1oTWa5Ai_BuiIHGFmeFolfZ14RQ130_assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276365.RAg2dltZvb6UtYXiyF1oTWa5Ai_BuiIHGFmeFolfZ14RQ130_provenance.
- NP1276363.RA97Lt3CB4Jy5aUSPEjgUP172I5V9uEQfV185k3tgLYek130_assertion description "[Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276363.RA97Lt3CB4Jy5aUSPEjgUP172I5V9uEQfV185k3tgLYek130_provenance.